Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
See Grinberg and Heinsen (doi:10.1093/brain/awx261) for a scientific commentary on this article. Clinical evidence suggests that aberrant tau accumulation in the locus coeruleus and noradrenergic dysfunction may be a critical early step in Alzheimer’s disease progression. Yet, an accurate preclinical model of these phenotypes that includes early pretangle tau accrual in the locus coeruleus, loss of locus coeruleus innervation and deficits locus coeruleus/norepinephrine modulated behaviours, does not exist, hampering the identification of underlying mechanisms and the development of locus coeruleus-based therapies. Here, a transgenic rat (TgF344-AD) expressing disease-causing mutant amyloid precursor protein (APPsw) and presenilin-1 (PS1ΔE9) was characterized for histological and behavioural signs of locus coeruleus dysfunction reminiscent of mild cognitive impairment/early Alzheimer’s disease. In TgF344-AD rats, hyperphosphorylated tau was detected in the locus coeruleus prior to accrual in the medial entorhinal cortex or hippocampus, and tau pathology in the locus coeruleus was negatively correlated with noradrenergic innervation in the medial entorhinal cortex. Likewise, TgF344-AD rats displayed progressive loss of hippocampal norepinephrine levels and locus coeruleus fibres in the medial entorhinal cortex and dentate gyrus, with no frank noradrenergic cell body loss. Cultured mouse locus coeruleus neurons expressing hyperphosphorylation-prone mutant human tau had shorter neurites than control neurons, but similar cell viability, suggesting a causal link between pretangle tau accrual and altered locus coeruleus fibre morphology. TgF344-AD rats had impaired reversal learning in the Morris water maze compared to their wild-type littermates, which was rescued by chemogenetic locus coeruleus activation via designer receptors exclusively activated by designer drugs (DREADDs). Our results indicate that TgF344-AD rats uniquely meet several key criteria for a suitable model of locus coeruleus pathology and dysfunction early in Alzheimer’s disease progression, and suggest that a substantial window of opportunity for locus coeruleus/ norepinephrine-based therapeutics exists.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The brain noradrenergic system is also critical for cognition and noradrengergic dysfunction is a critical early step in AD progression 249.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [249]
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
The locus coeruleus and noradrenergic modulation of cognition
Sara, S. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2573 · Cited by 1,848
The efficiency of systematic sampling in stereology—reconsidered
GUNDERSEN, H. J. G., JENSEN, E. B. V., KIÊU, K., & NIELSEN, J. (1999) · Journal of Microscopy · doi:10.1046/j.1365-2818.1999.00457.x · Cited by 1,317
Augustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998
The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies)
Amaral, D. G., Scharfman, H. E., & Lavenex, P. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63001-5 · Cited by 888
Al-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765
Cited by
Items 101–200 of 229
Neuroprotective actions of norepinephrine in neurological diseases
Ghasemi, M., & Mehranfard, N. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-02999-w · Cited by 16
“…vagus nerve stimulation and chemogenetic LC activation were found to enhance NE concentration in certain brain regions related to cognition such as the hippocampus and cerebral cortex [64] and ameliorate cognitive impairments in AD dementia patients [30] as well as in a rat model of AD [178].”
Cognitive Impairment in Alzheimer’s and Metabolic Diseases: A Catecholaminergic Hypothesis
Guzmán-Ramos, K. R., Osorio‐Gómez, D., & Bermúdez‐Rattoni, F. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.05.031 · Cited by 15
Lawson, K. A., Ruiz, C. M., & Mahler, S. V. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06429-0 · Cited by 24
On the origin of tau seeding activity in Alzheimer’s disease
Heinsen, H., & Grinberg, L. T. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1890-3 · Cited by 15
Hiraga, T., Hata, T., Soya, S., Shimoda, R., Takahashi, K., Soya, M., Inoue, K., Johansen, J. P., Okamoto, M., & Soya, H. (2024) · The FASEB Journal · doi:10.1096/fj.202400418rrr · Cited by 17
Contextual memory engrams, and the neuromodulatory influence of the locus coeruleus
Grella, S. L., & Donaldson, T. N. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1342622 · Cited by 16
Pahl, J., Prokopiou, P. C., Bueichekú, E., Schultz, A. P., Papp, K. V., Farrell, M. E., Rentz, D. M., Sperling, R. A., Johnson, K. A., & Jacobs, H. I. L. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01485-w · Cited by 19
Dentate Granule Cells Are Hyperexcitable in the TgF344-AD Rat Model of Alzheimer's Disease
Smith, L. A., Goodman, A. M., & McMahon, L. L. (2022) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2022.826601 · Cited by 13
“, 2021), a rodent model that more fully recapitulates AD-like pathology in an age-dependent manner (Cohen et al., 2013; Do Carmo and Cuello, 2013; Tsai et al., 2014; Joo et al., 2017; Rorabaugh et al., 2017; Bazzigaluppi et al., 2018; Muñoz-Moreno et al., 2018; Pentkowski et al., 2018; Smith and McMahon, 2018; Voorhee…”
BackgroundInfluentialInsulin and disorders of behavioural flexibility
Sullivan, M., Fernández‐Aranda, F., Camacho‐Barcia, L., Harkin, A., Macrì, S., Mora‐Maltas, B., Jiménez‐Múrcia, S., O’Leary, A., Ottomana, A. M., Presta, M., et al. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105169 · Cited by 17
“However, several AD animal models have been shown to have deficits in set-shifting and reversal learning tasks, mostly in aged animals (108, 115, 238, 239, 265), reviewed in (326).”
BackgroundOgg, M. C., Lansdell, B., Franks, H. T., Hughes, A. C., Lee, J., Nolen, H. G., Shirinifard, A., & Schwarz, L. A. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116687 · Cited by 12
Venular amyloid accumulation in transgenic Fischer 344 Alzheimer’s disease rats
Bishay, J., Beckett, T. L., Lai, A. Y., Hill, M. E., McMahon, D., & McLaurin, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-19549-y · Cited by 10
Light at the beginning of the tunnel? Investigating early mechanistic changes in Alzheimer’s disease
Grinberg, L. T., & Heinsen, H. (2017) · Brain · doi:10.1093/brain/awx261 · Cited by 12
Spatio-temporal metabolic rewiring in the brain of TgF344-AD rat model of Alzheimer’s disease
Muñoz‐Moreno, E., Simoes, R. V., Tudela, R., López-Gil, X., & Sòria, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-20962-6 · Cited by 11
Hernández‐Martín, N., Martínez, M. G., Bascuñana, P., de la Rosa, R. F., García‐García, L., Gómez-Oliver, F., Solas, M., Martín, E. D., & Pozo, M. A. (2024) · Glia · doi:10.1002/glia.24607 · Cited by 12
“…widely studied by evaluating their behavioral consequences both under normal and under neuropathological conditions such as in rat models of Alzheimer's disease or of temporal lobe epilepsy (Alami et al., 2020; Alcaraz et al., 2018; Goossens et al., 2019; Kang et al., 2020; Rorabaugh et al., 2017).”
Stevens, L., Vonck, K. E. J., Larsen, L. E., Lysebettens, W. V., Germonpré, C., Baekelandt, V., den Haute, C. V., Carrette, E., Wadman, W. J., Boon, P., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00162 · Cited by 12
Rat models of major neurodegenerative disorders
Novati, A., Singer, E., Yu-Taeger, L., Clemensson, E. K. H., & Nguyen, H. P. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.19 · Cited by 13
Hartner, J. P., & Schrader, L. A. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00003 · Cited by 14
“Furthermore, noradrenergic innervation in the MEC is reduced in rodent models of AD (Chalermpalanupap et al., 2017; Rorabaugh et al., 2017).”
BackgroundQuattrini, G., Pini, L., Galazzo, I. B., Jelescu, I., Jovicich, J., Manenti, R., Frisoni, G. B., Marizzoni, M., Pizzini, F. B., & Pievani, M. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12513 · Cited by 12
Waegenaere, S. D., van den Berg, M., Keliris, G. A., Adhikari, M. H., & Verhoye, M. (2024) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2024.1379923 · Cited by 9
Hernandez, C. M., McCuiston, M. A., Davis, K., Halls, Y., Zotto, J. P. C. D., Jackson, N. L., Dobrunz, L. E., King, P. H., & McMahon, L. L. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100798 · Cited by 11
“Whereas others have shown early impairments on hippocampal-dependent learning and memory (Bernaud et al., 2022; Kelberman et al., 2022; Rorabaugh et al., 2017), and we have shown early impairments in BLA-dependent memory (Hernandez et al., 2022a), in our current study, we showed evidence for early…”
InfluentialExamining resilience to Alzheimer’s disease through the lens of monoaminergic neuromodulator systems
Crawford, J. L., & Berry, A. S. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.09.004 · Cited by 12
Insights From TgF344-AD, a Double Transgenic Rat Model in Alzheimer’s Disease Research
Nataraj, A., Blahna, K., & Ježek, K. (2025) · Physiological Research · doi:10.33549/physiolres.935464 · Cited by 10
Linking Social Cognition, Parvalbumin Interneurons, and Oxytocin in Alzheimer’s Disease: An Update
Černotová, D., Hrůzová, K., Levčík, D., Svoboda, J., & Stuchlík, A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230333 · Cited by 12
“Progressive worsening of spatial learning and reference memory then first appears around five to six months [31–34], although some authors reported memory deficits starting even later—around nine to ten months of age in mice [19, 35, 36] and seven to eight months in rats [37].”
BackgroundAging pattern of the brainstem based on volumetric measurement and optimized surface shape analysis
Hu, M., Xu, F., Liu, S., Yao, Y., Xia, Q., Zhu, C., Zhang, X., Tang, H., Qaiser, Z., Liu, S., et al. (2023) · Brain Imaging and Behavior · doi:10.1007/s11682-023-00840-z · Cited by 12
Ceyzériat, K., Jaques, E., Gloria, Y., Badina, A. M., Millet, P., Koutsouvelis, N., Dipasquale, G., Frisoni, G. B., Zilli, T., Garibotto, V., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231153 · Cited by 11
“…and/or memory alterations at the age of 4 [21], 9–12 [16, 22–26], 15 [16], and 24 [16, 24] months or impaired reversal learning at 6 months [27], whereas other did not report any difference compared to WT animals at 4–6 [23, 28–30], 7–11 [23], 13 [30], 15–18 [31], and 24 [31, 32] months of…”
Kolinko, Y., Maršálová, L., Pena, S. P., Králíčková, M., & Mouton, P. R. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210738 · Cited by 10
“lived TgF344-AD rats after 12 months of age displayed pronounced deficits in memory and navigation [61–63] combine with progressive loss of hippocampal norepinephrine levels, especially in DG [60].”
BackgroundDammer, E. B., Shantaraman, A., Ping, L., Duong, D. M., Gerasimov, E. S., Ravindran, S. P., Guðmundsdóttir, V., Frick, E. A., Gómez, G., Walker, K. A., et al. (2023) · medRxiv · doi:10.1101/2023.10.29.23297651 · Cited by 10
Miyake, T., Tanaka, K., Inoue, Y., Nagai, Y., Nishimura, R., Seta, T., Nakagawa, S., Inoue, K., Hasegawa, E., Minamimoto, T., et al. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100881 · Cited by 11
Ganzoni, R. L. Z., Bournons, S. S., Carreira, E. M., Bundel, D. D., & Smolders, I. J. (2025) · Medicinal Research Reviews · doi:10.1002/med.22105 · Cited by 10
Wissing, C., Eschholz, L. S., Maheu, M., Sauter, K., Morellini, F., Wiegert, J. S., & Dieter, A. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003228 · Cited by 20
“[43,44], which attributed the lack of transgene expression to off-target virus administration (i.e., injection in brain regions adjacent to LC).”
Singhaarachchi, P. H., Antal, P., Calon, F., Culmsee, C., Delpech, J.-C., Feldotto, M., Geertsema, J., Hoeksema, E. E., Kőrösi, A., Layé, S., et al. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102821 · Cited by 13
Pharmacosynthetic Deconstruction of Sleep-Wake Circuits in the Brain
Varin, C., & Bonnavion, P. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_183 · Cited by 10
“…of DREADD technique to LC NA neurons has been also used to stimulate degenerating neurons and test beneficial effects of increasing brain NA levels on cognitive impairments in a mouse model of Down syndrome (Rorabaugh et al. 2017) and in a rat model of Alzheimer’s disease (Fortress et al. 2015).”
MethodLing, W., Cui, Y., Gao, J., Jiang, X., Wang, R. C., Tian, Y., Sheng, H., & Cui, J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.083 · Cited by 8
Hajj, R. E., Sagheer, T. A., & Ballout, N. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.25321 · Cited by 10
Stevens, L., Larsen, L. E., Lysebettens, W. V., Carrette, E., Boon, P., Raedt, R., & Vonck, K. E. J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.663337 · Cited by 8
Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease
Matt, R. A., Martin, R. S., Evans, A. K., Gever, J. R., Vargas, G. A., Shamloo, M., & Ford, A. P. D. W. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_677 · Cited by 12
Betts, M. J., Ehrenberg, A. J., Hämmerer, D., & Düzel, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00401 · Cited by 8
Dahl, M. J., Mather, M., Düzel, S., Bodammer, N. C., Lindenberger, U., Kühn, S., & Werkle‐Bergner, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/332098 · Cited by 9
Rethinking early Alzheimer’s disease: An impaired internal model updating disorder?
Antonioni, A. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106790 · Cited by 9
Schneider, C., Prokopiou, P. C., Papp, K. V., Engels, N., Hsieh, S., Juneau, T., Schultz, A. P., Rentz, D. M., Sperling, R. A., Johnson, K. A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13839 · Cited by 9
Dahl, M. J., Bachman, S. L., Dutt, S., Düzel, S., Bodammer, N., Lindenberger, U., Kühn, S., Werkle‐Bergner, M., & Mather, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.12.511748 · Cited by 6
Zhang, J., Chen, K., & Chen, F. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101077 · Cited by 10
“Alterations in the hippocampus contribute to age-related cognitive decline and central nervous system diseases [27].”
Downs, A. M., Kmiec, G., Catavero, C. M., Wykoff, L. A., & McElligott, Z. A. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106883 · Cited by 8
“While AD-like pathology is driven by different transgenes in these rats, pre-tangle tau does accumulate in the LC of the TgF344-AD rat starting at 6 months (Rorabaugh et al., 2017).”
Hall, S. E., White, Z. J., Rohn, T. T., Sudasinghe, K., & Young, M. E. (2025) · Brain Sciences · doi:10.3390/brainsci15060631 · Cited by 9
“TgF344-AD animals display early cognitive deficits at 6 months of age, with pronounced learning impairment and significant neuronal loss at 15 months [24,28].”
Reitz, N. L., Nunes, P. T., & Savage, L. M. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1448691 · Cited by 5
Wissing, C., Eschholz, L. S., Maheu, M., Sauter, K., Morellini, F., Wiegert, J. S., & Dieter, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.22.477348 · Cited by 6
Hernandez, A. R., Parker, E. S., Babar, M., Banerjee, A., Ding, S., Simley, A. L., & Buford, T. W. (2024) · Aging Brain · doi:10.1016/j.nbas.2024.100119 · Cited by 5
“Though there is evidence of impaired reversal learning [13], fear memory extinction in males [15], and spatial navigation [17], there is a dearth of information regarding higher order tasks requiring the integration of information across several brain structures in these transgenic rats.”
BackgroundSleeve gastrectomy attenuated diabetes-related cognitive decline in diabetic rats
Ding, H., Liu, C., Zhang, S., Li, B., Xu, Q., Shi, B., Li, S., Dong, S., Ma, X., Zhang, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1015819 · Cited by 5
“Changes in the hippocampus tissue underlie cognitive decline as central nervous system diseases and diabetes progress (27, 28).”
BackgroundDeurveilher, S., Antonchuk, M., Saumure, B. S. C., Baldin, A., & Semba, K. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15412 · Cited by 5
“studies (Modirrousta et al., 2005; Rorabaugh et al., 2017) and optimized so that they would produce total counts of 150–200 cells for each immunostained neuronal population in each brain, with a Gundersen coefficient of error <0.”
MethodInfluentialMarsland, P., Vore, A. S., Lutzke, A., Gano, A., Fischer, A., Trapp, S., Savage, L. M., & Deak, T. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.034 · Cited by 4
The monoaminergic systems as drivers of Alzheimer's disease pathophysiology and symptomatology
Jacobs, H. I. L. (2026) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001455 · Cited by 5
Cicco, V. D., Fantozzi, M. P. T., Ligori, S., Cataldo, E., Cicco, D. D., Bongioanni, P., Dolciotti, C., Bruschini, L., Faraguna, U., & Manzoni, D. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111528 · Cited by 4
Characterization of locus coeruleus neuronal properties with aging in two mouse models of tauopathy
Potts, Y., Daykin, H. J., Bossche, M. J. A. V. D., McDougall, S. J., & Jacobson, L. H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251393515 · Cited by 4
Engels, N., Koops, E. A., Hsieh, S., Wiklund, E. E., Schultz, A. P., Riphagen, J. M., Prokopiou, P. C., Hanseeuw, B. J., Rentz, D. M., Sperling, R. A., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01500-0 · Cited by 6
“…TgF344-AD rats expressing mutant amyloid precursor protein, pre-senilin-1, and age-dependent endogenous hyperphosphorylated tau in the LC, accumulation of tau in the LC resulted in decreased NE signaling and overall dysregulated NE as well as reductions in LC fiber density to the cortex [9].”
Backgroundde Ávila, C., Guguła, A., Trenk, A., Intorcia, A. J., Suazo, C., Nolz, J., Plamondon, J., Khatri, D., Tallant, L., Caron, A., et al. (2024) · Biological Research · doi:10.1186/s40659-024-00523-z · Cited by 5
“Brainstem networks including those ascending from the LC and the raphe nuclei are highly susceptible to neurodegenerative diseases, including AD [79–82], and phosphorylated-tau has been used as a marker of neurodegeneration in diseases such as Alzheimer’s disease and related dementias (ADRD)…”
MethodFutácsi, A., Rusznák, K., Szarka, G., Völgyi, B., Wiborg, O., & Czéh, B. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1542229 · Cited by 6
Dahl, M. J., Werkle‐Bergner, M., & Mather, M. (2020) · medRxiv · doi:10.17605/osf.io/sf2ky · Cited by 6
Dahl, M. J., Mather, M., Düzel, S., Bodammer, N., Lindenberger, U., Kühn, S., & Werkle‐Bergner, M. (2019) · MPG.PuRe (Max Planck Society) · Cited by 5
van den Berg, M., Adhikari, M. H., Verschuuren, M., Pintelon, I., Vasilkovska, T., Audekerke, J. V., Missault, S., Heymans, L., Ponsaerts, P., Vos, W. H. D., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1791270/v1 · Cited by 4
The locus coeruleus, a blue spot for early diagnosis and prognosis of Alzheimer’s disease
Farahani, F., Anaclet, C., Azizi, H., & Gompf, H. S. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1632236 · Cited by 4
Stapleton, H. M., Borges, D. D. S., Trindade, E. B. S. D. M., & Yuan, Q. (2026) · Biology of Sex Differences · doi:10.1186/s13293-026-00834-8 · Cited by 3
“…models, including fibril seeding in PS19 and P301 lines [40, 41], LC-targeted pseu-dophosphorylated tau (htauE14) [42], and TgF344-AD models [27], tau pathology arises early, producing axonal degeneration, circuit dysfunction, and learning impairments prior to widespread cortical tangle…”
Korukonda, A., Blankenship, H. E., Kam, K., Kour, D., Espinosa‐García, C., Jang, W. E., Srivastava, U., Mulvey, B., Tish, M. M., Witztum, R., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03852-5 · Cited by 6
Self-citationTransient strain differences in an operant delayed non-match to position task
Gohar, T., Ciacciarelli, E. J., Dunn, S. D., & West, E. A. (2023) · Behavioural Processes · doi:10.1016/j.beproc.2023.104932 · Cited by 3
Ciacciarelli, E. J., Dunn, S. D., Gohar, T., Sloand, T. J., Niedringhaus, M. S., & West, E. A. (2024) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2024.108007 · Cited by 8
Černotová, D., Hrůzová, K., Touš, J., Janča, R., Stuchlík, A., Levčík, D., & Svoboda, J. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106875 · Cited by 3
“Tau pathology in the hippocampus typically emerges later, around 16 – 18 months (Cohen et al., 2013; Rorabaugh et al., 2017; Chaney et al., 2021).”
Sloand, T. J., Dunham, B. P., Niedringhaus, M. S., & West, E. A. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.1387-25.2026 · Cited by 3
Kabanova, A., Fedorov, L., & Eschenko, O. (2024) · eNeuro · doi:10.1523/eneuro.0063-24.2024 · Cited by 4
“Other studies have demonstrated that in a nonspatial context, a higher LC activity predicted faster behavioral switching to a new rule (Kane et al., 2017; Rorabaugh et al., 2017; McBurney-Lin et al., 2022).”
Plini, E. R. G., Robertson, I. H., Brosnan, M. B., & Dockree, P. M. (2024) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_02245 · Cited by 3
Multimodal Gamma Stimulation Improves Activity but not Memory in Aged Tgf344-AD Rats
Bentley, J. H., & Broussard, J. I. (2023) · Current Alzheimer Research · doi:10.2174/0115672050281956240228075849 · Cited by 3
Gálvez-Márquez, D. K., Urrego-Morales, O., Rodríguez-Durán, L. F., & Bermúdez‐Rattoni, F. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06885-w · Cited by 4
Impact of early locus coeruleus lesions in the TgF344 Alzheimer's disease rat model
Marriott, A., Schroeder, J. P., Korukonda, A., Pate, B. S., McCann, K. E., Weinshenker, D., & Kelberman, M. A. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71334 · Cited by 2
Self-citationvan Rooij, J. R. A., van den Berg, M., Vosselen, M. V., Calus, E., Vasilkovska, T., Kosten, L., Spilbeeck, I. V., Audekerke, J. V., Dam, D. V., Bertoglio, D., et al. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115647 · Cited by 2
Decoding the mechanisms of amyloid-β in synaptic toxicity
Toruński, P., Pizzirusso, G., Winblad, B. G., & Arroyo‐García, L. E. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261424292 · Cited by 4
A new hope: locus coeruleus-norepinephrine system at the nexus of neuropsychiatric symptoms
Korukonda, A., & Weinshenker, D. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03696-z · Cited by 3
“Correspondingly, TgF344-AD rats exhibit reductions in hippocampal NE fi bers and content as pathology progresses [66].”
InfluentialSelf-citationSpatial navigation and Alzheimer's disease
Berkowitz, L. E., Harvey, R. E., & Clark, B. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00043-8 · Cited by 2
Chemogenetic Tools and their Use in Studies of Neuropsychiatric Disorders
Neřoldová, M., & Stuchlík, A. (2024) · Physiological Research · doi:10.33549/physiolres.935401 · Cited by 2
Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome
Saternos, H., Hamlett, E. D., Guzman, S. J., Head, E., Granholm, A., & Ledreux, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240043 · Cited by 4
Reitz, N. L., Nunes, P. T., & Savage, L. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.17.603911 · Cited by 2
“The Morris Water Maze (MWM), a standard test for hippocampus-dependent spatial memory, reveals deficits in reversal learning as early as 6 months old, persisting until 16 months (Berkowitz et al., 2018; Rorabaugh et al., 2017; Voorhees et al., 2019).”
BackgroundSun, J., Zou, Y., Xiu, G., Lin, B., & Liu, S. (2018) · Ibrain · doi:10.1002/j.2769-2795.2018.tb00026.x · Cited by 1
Abu‐Labdeh, R., Omoluabi, T., & Yuan, Q. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16649 · Cited by 1
“Chemogenetic activation of the LC has been shown to improve spatial reversal learning in a rodent model of Alzheimer's disease (AD) (Rorabaugh et al. 2017), contrasting with the adverse effects of higher doses of ATM on reversal learning in healthy rats in our study.”
Isoflurane Exposure Influence on Sleep Architecture in a Rat Model of Alzheimer's Disease.
Kreuzer, M., Keating, G. L., Sinon, C. G., Fenzl, T., Schneider, G., Rye, D. B., & García, P. S. (2025) · Anesthesia and Analgesia · doi:10.1213/ane.0000000000007717 · Cited by 1
Brain, CSF, and Blood Metabolomics Signature in the TgF344-AD Rat Model of Alzheimer’s Disease
Samey, R. A., Mavel, S., Ceyzériat, K., Chalon, S., Nadal‐Desbarats, L., Bodard, S., Lefèvre, A., Busson, J., Chicheri, G., Antier, D., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00047 · Cited by 1
Hilner, J. M., Turner, A., Vollmar-Zygarlenski, C., & Millet, L. J. (2025) · Biosensors · doi:10.3390/bios15110727 · Cited by 2
Laczó, M., Malenínská, K., Khazaalova, N., Borovská, Š., Vyhnálek, M., HORT, J. F., Stuchlík, A., Svoboda, J., & Laczó, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-36266-y · Cited by 1
“…dentate gyrus 78,80,81 , and restoration of reversal learning deficits after chemogenetic activation of the locus coeruleus in 16-month-old TgF344-AD rats 78 , supporting a potential mechanistic link between early AD-related neuropathological changes and hippocampus-dependent memory discrimination.”
Nasim, N., Cheng, M.-Y., Park, H. H., Valenzuela, A., Andrew, P., Wexler, A. S., Chandrasekaran, V., Winkle, L. S. V., Bein, K. J., & Lein, P. J. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103472 · Cited by 1
Bishay, J., Beckett, T. L., Lai, A. Y., Hill, M. E., McMahon, D., & McLaurin, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1739433/v1 · Cited by 1
Downs, A. M., Kmiec, G., Catavero, C. M., & McElligott, Z. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.17.633373 · Cited by 3
“While AD-like pathology is driven by different transgenes rats, pre-tangle tau does accumulate in the LC of the TgF344-AD rat starting at 6 months (Rorabaugh et al. , 2017).”
Winslow, M. (2019) · ScholarWorks (Boise State University) · doi:10.18122/td/1567/boisestate
“This indicates that memory dysfunction occurs prior to significant plaque and NFT accumulation, as previous work with this model showed no significant accumulation at 9 m and significant accumulation by 15 m (Cohen et al., 2013; Rorabaugh et al., 2017).”
BackgroundMethodResultInfluentialKang, S. S., Liu, X., Ahn, E. H., Xiang, J., Manfredsson, F. P., Yang, X., Luo, H. R., Liles, L. C., Weinshenker, D., & Ye, K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/688200
Self-citationKelberman, M. A., Anderson, C. R., Chlan, E., Rorabaugh, J. M., McCann, K. E., & Weinshenker, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.30.466530
Self-citationBernaud, V. E., Bulen, H. L., Peña, V., Koebele, S. V., Northup-Smith, S. N., Manzo, A. A., Sanchez, M. V., Opachich, Z., Ruhland, A. M., & Bimonte‐Nelson, H. A. (2022) · Research Square · doi:10.21203/rs.3.rs-1482938/v1
Candesartan treatment preserves learning and working memory in female TgF344-AD ratsPreprint
Sinon, C. G., Carter, K., Ma, J., Bagchi, P., Zhang, X., Williams, P.-J. C., Dammer, E. B., Seyfried, N. T., García, P. S., Sutliff, R. L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.14.496112
“While some studies have shown deficits in reversal learning as early as six months and impaired performance on learning and reference memory tasks at 10- to 12-months of age when compared to WT rats[52-54], other groups have found no difference between WT and TgF344-”
ResultImaging early brain characteristics of alzheimer’s disease: Structure, function and symptomatology
van Hooren, R. W. E. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20221215rh
de Ávila, C., Guguła, A., Trenk, A., Intorcia, A. J., Suazo, C., Nolz, J., Plamondon, J., Khatri, D., Tallant, L., Caron, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.08.556922
“Possible impact of AD pathology on NI RLN3 neurons 334 Brainstem networks including those ascending from the LC and the raphe nuclei are highly 335 susceptible to neurodegenerative diseases, including AD [79-82], and phosphorylated-tau has been 336 used as a marker of neurodegeneration in diseases such as Alzheimer’s…”
MethodDutton, O. D. E., Wasef, M. A., Burke, A. T., Chirinos, E. A., Jones, A. T., Vey, R., Skinner, D. M., Harley, C. W., & Walling, S. G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.05.565692
“…models under the influence of functional and evoked, phasic and tonic stimulation as chemogenetic manipulation of LC neurons in Tg F344-AD rats (Rorabaugh et al., 2017), and phasic, but not tonic optogenetic stimulation in the LC-htauE14 model (Omoluabi et al., 2021) rescued behavioural…”
BackgroundXiao, W., Su, J., Gao, X., Yang, H., Weng, R., Ni, W., & Gu, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19609524
Xiao, W., Su, J., Gao, X., Yang, H., Weng, R., Ni, W., & Gu, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19609527
Černotová, D., Malenínská, K., Hořáková, A., Rudolfová, V., Stuchlík, A., & Svoboda, J. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115820 · Cited by 1
Kim, A. J., Morales, S., Senior, J. A., & Mather, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.02.680040
Long-term locus coeruleus stimulation exacerbates tau pathology in PS19 mice
Nong, Y., Wellman, S. M., Zhang, H., Liu, Y., Argyrousi, E. K., Arancio, O., & Wang, Q. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261468577 · Cited by 1
“18 20 – 22 Furthermore, elevated NE levels have been reported in some AD patients.”
Metadata
- Authors
- Rorabaugh, J. M., Chalermpalanupap, T., Botz-Zapp, C. A., Fu, V. M., Lembeck, N. A., Cohen, R. M., & Weinshenker, D.
- Affiliations
- Emory University (US)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-25
- Volume
- 140
- Issue
- 11
- Pages
- 3023-3038
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC5841201
- OpenAlex
- W2760256027
- Cited by
- 227
- References
- 72
- Citations by year
- 2026: 24 · 2025: 25 · 2024: 39 · 2023: 20 · 2022: 45 · 2021: 26 · 2020: 18 · 2019: 14 · 2018: 13 · 2017: 3
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AG0476670, NS007480)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- locus coeruleus, Alzheimer's disease, reversal learning, tau hyperphosphorylation, noradrenergic dysfunction, norepinephrine, TgF344-AD rats, medial entorhinal cortex, DREADD, chemogenetic activation, mild cognitive impairment, preclinical models
- MeSH terms
- Alzheimer Disease, Animals, Cells, Cultured, Disease Models, Animal, Female, Locus Coeruleus, Male, Rats, Inbred F344, Reversal Learning, tau Proteins, Maze Learning, Rats, Rats, Transgenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.